ArticleMolecular imaging and biology2013

Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy.

Madhuri Sankaranarayanapillai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.